Move to Main Content
搜尋
Find Medical Services
0
Language
選單按鈕
:::
  • Home
  • Patient Testimonials

Patient Testimonials

  • Crossing Thousands of Miles to End a Decade of Pain: CYCH International Medical Aid Helps a Mongolian Youth Run Toward the Future

    Crossing Thousands of Miles to End a Decade of Pain: CYCH International Medical Aid Helps a Mongolian Youth Run Toward the Future

    Crossing Thousands of Miles to End a Decade of Pain: CYCH International Medical Aid Helps a Mongolian Youth Run Toward the Future On the vast Mongolian steppes, 30-year-old Ermuun was once a young man who loved football, basketball, and traditional Mongolian wrestling. However, at the age of 20, he began suffering from severe, recurrent headaches of unknown cause, forcing him to rely heavily on painkillers. In Mongolia, where medical resources are relatively limited and many medications are imported with unclear ingredients and sources, long-term use of such drugs gradually posed serious health risks.o:p>/o:p> Several years later, Ermuun developed severe pain in both hip joints. He frequently felt his hips locking while walking and was unable to stand for long periods. After medical examinations, he was diagnosed with bilateral avascular necrosis of the femoral heads, a condition suspected to be related to prolonged use of unidentified medications. At a critical stage of his life, he was told that he would no longer be able to run or jump and would have to live with chronic pain. Facing high surgical costs and limited local medical expertise, doctors in Mongolia even advised him to “consider surgery after the age of 50,” a recommendation that deeply shattered his hopes for the future.o:p>/o:p> A turning point came through a cross-border short-term medical mission. In June 2025, Chou Tien-Hung, Vice Superintendent of Chiayi Christian Hospital (CYCH), together with a service team from the Evangelical Lutheran Church in Taiwan, traveled to Mongolia for medical outreach and assessment. Ermuun assisted the Taiwanese team with reception and transportation during their visit, giving Vice Superintendent Chou the opportunity to learn about his condition and needs. This unexpected encounter became the crucial link that connected Ermuun to international medical assistance—and a chance to change his destiny.o:p>/o:p> After returning to Taiwan, Vice Superintendent Cho consulted Dr. Chen Chun-Ho, Director of International Medical Services and an orthopedic specialist at CYCH. The case was identified as a rare instance of early-onset bilateral hip joint destruction. Following comprehensive cross-border online professional evaluations, the medical team confirmed that Ermuun’s hip joints were severely damaged and had significantly impaired his daily functioning. The team then proposed an international medical aid plan and invited him to Taiwan for further treatment. For Ermuun, this journey across thousands of miles was filled with uncertainty—but also hope.o:p>/o:p> Upon arriving in Taiwan, Ermuun underwent thorough examinations and discussions with the medical team at CYCH. He decided to proceed with bilateral direct anterior approach total hip arthroplasty, a surgical technique that minimizes muscle damage, reduces postoperative pain, and accelerates recovery. For a young man who had endured years of pain, this decision represented a renewed investment in his future.o:p>/o:p> Dr. Chen Chun-Ho explained that in Taiwan, with a mature healthcare system, world-class prosthetic materials, and advanced surgical techniques, avascular necrosis of the hip is not an unsolvable condition. He therefore collaborated with orthopedic surgeon Dr. Tsai Ting-Chien to perform the direct anterior approach hip replacement, which is especially suitable for young patients with bilateral disease, as it balances mobility, durability, and long-term functional outcomes.o:p>/o:p> On the second day after surgery, Ermuun experienced something he had not felt in over a decade—a body without pain. As he slowly took his first steps in the hospital ward, a smile returned to his face. He can now walk with ease and has even grown 2 centimeters taller. Within days, he was preparing to return home. Reflecting on his journey, he shared emotionally:o:p>/o:p> “God can use pain to shape me, and He can also miraculously take it away when I can no longer bear it. Ten years of pain ended on that day.”o:p>/o:p> These words encapsulate a young man’s journey from despair to renewal.o:p>/o:p> On January 29, 2026, just before Ermuun’s return to Mongolia, CYCH held an International Medical Aid Press Conference to share and celebrate this cross-border medical mission. Special recognition was given to United Orthopedic Corporation, a leading domestic developer of orthopedic implants, for its enthusiastic support, including partial sponsorship of two sets of premium-quality artificial hip joints. This collaboration played a vital role in ensuring the success of the international medical aid effort.o:p>/o:p> Vice Superintendent Chou Tien-Hung stated that with the support of the CYCH Humanitarian and Overseas Care Fund and United Orthopedic Corporation, the patient’s financial burden was significantly reduced, while ensuring access to the highest-quality and most durable hip prostheses for long-term use over the coming decades. The dedication of the medical team enabled international medical assistance to be delivered in a more comprehensive and safe manner, demonstrating the powerful partnership between medical professionalism and social responsibility.o:p>/o:p> Vice Superintendent Chou further emphasized that medical care itself is an act of compassion, and international medical missions extend that compassion to distant places.o:p>/o:p> “When we met Ermuun in Mongolia and saw both his pain and his hope, we knew this was not just a medical case, but a life waiting to be answered.”o:p>/o:p> He highlighted that CYCH’s ability to bring medical expertise, compassion, and hope to regions with limited medical resources—helping a young life stand up again and move toward the future—embodies the deepest value of international medical aid: not just healing illness, but transforming lives.o:p>/o:p> Dr. Chen Chun-Ho added that while surgical success is important, what moved him most was seeing the patient stand again without pain.o:p>/o:p> “In that moment, it wasn’t just a joint that was repaired—it was a person regaining confidence in the future.”o:p>/o:p> He noted that being part of an initiative that combines medicine with love is a rare and deeply meaningful experience in a physician’s career.o:p>/o:p>

    #Joint Replacement
  • 【Tungs Hospital】Abnormal Menstrual Bleeding Led to the Diagnosis of Uterine Fibroids

    【Tungs Hospital】Abnormal Menstrual Bleeding Led to the Diagnosis of Uterine Fibroids

    44y Patient Shares clinical experience in da Vinci SP gynecologic surgery, along with information on uterine fibroids and treatment considerations. figure data-wp-context="{"uploadedSrc":"https:\/\/tconf.sltung.com.tw\/imc\/wp-content\/uploads\/sites\/2\/2026\/01\/da-vinci-sp-gynecology-observation-center-tungs-hospital-1.jpg","figureClassNames":"wp-block-image aligncenter size-full","figureStyles":null,"imgClassNames":"wp-image-10266","imgStyles":null,"targetWidth":940,"targetHeight":593,"scaleAttr":false,"ariaLabel":"Enlarge image: da-vinci-sp-gynecology-observation-center-tungs-hospital","alt":"da-vinci-sp-gynecology-observation-center-tungs-hospital"}" data-wp-interactive="core/image" class="wp-block-image aligncenter size-full wp-lightbox-container" style="box-sizing: inherit; margin: 0px auto; border: 0px; font-style: inherit; font-weight: inherit; outline: 0px; padding: 0px; vertical-align: baseline; clear: both; text-align: center; display: table; flex-direction: column; position: relative; width: 796px; min-width: unset !important;">svg xmlns="http://www.w3.org/2000/svg" width="12" height="12" fill="none" viewbox=""> path fill="#fff" d="M2 0a2 2 0 0 0-2 2v2h1.5V2a.5.5 0 0 1 .5-.5h2V0H2Zm2 10.5H2a.5.5 0 0 1-.5-.5V8H0v2a2 2 0 0 0 2 2h2v-1.5ZM8 12v-1.5h2a.5.5 0 0 0 .5-.5V8H12v2a2 2 0 0 1-2 2H8Zm2-12a2 2 0 0 1 2 2v2h-1.5V2a.5.5 0 0 0-.5-.5H8V0h2Z">/path> /svg>/figure> Gynecologic da Vinci Single-Port (SP) Surgery Observation Center Established On January 20, 2026, Tungs’ Taichung MetroHarbor Hospital established the Gynecologic da Vinci Single-Port (SP) Surgery Observation Center, reflecting the hospital’s continued development and clinical experience in advanced minimally invasive gynecologic surgery. According to Dr. Chin-Cheng Liu, Director of the Department of Obstetrics and Gynecology, minimally invasive surgery has become an important trend in modern gynecologic care. The da Vinci Single-Port (SP) system allows complex procedures to be performed through a single incision of approximately 2.5 cm, offering an alternative minimally invasive approach for gynecologic surgery. figure data-wp-context="{"uploadedSrc":"https:\/\/tconf.sltung.com.tw\/imc\/wp-content\/uploads\/sites\/2\/2026\/01\/da-vinci-sp-gynecology-center-opening-1.jpg","figureClassNames":"wp-block-image aligncenter size-full","figureStyles":null,"imgClassNames":"wp-image-10265","imgStyles":null,"targetWidth":940,"targetHeight":788,"scaleAttr":false,"ariaLabel":"Enlarge image: da-vinci-sp-gynecology-center-opening","alt":"da-vinci-sp-gynecology-center-opening"}" data-wp-interactive="core/image" class="wp-block-image aligncenter size-full wp-lightbox-container" style="box-sizing: inherit; margin: 0px auto; border: 0px; font-style: inherit; font-weight: inherit; outline: 0px; padding: 0px; vertical-align: baseline; clear: both; text-align: center; display: table; flex-direction: column; position: relative; width: 796px; min-width: unset !important;">svg xmlns="http://www.w3.org/2000/svg" width="12" height="12" fill="none" viewbox=""> path fill="#fff" d="M2 0a2 2 0 0 0-2 2v2h1.5V2a.5.5 0 0 1 .5-.5h2V0H2Zm2 10.5H2a.5.5 0 0 1-.5-.5V8H0v2a2 2 0 0 0 2 2h2v-1.5ZM8 12v-1.5h2a.5.5 0 0 0 .5-.5V8H12v2a2 2 0 0 1-2 2H8Zm2-12a2 2 0 0 1 2 2v2h-1.5V2a.5.5 0 0 0-.5-.5H8V0h2Z">/path> /svg>/figure> The hospital stated that since introducing the latest-generation da Vinci Single-Port robotic surgical system in May 2025, the gynecology department has completed 142 SP procedures as of January 2026, ranking first nationwide. Through multidisciplinary collaboration, including gynecology and urology, the total number of single-port procedures at the hospital has exceeded 300 cases. Dr. Liu is also the first gynecologist in Taiwan certified as an instructor for both the da Vinci Xi and SP systems, and serves as an instructor at the Gynecologic da Vinci Single-Port Surgery Observation Center, sharing clinical experience and surgical techniques. Abnormal Menstrual Bleeding Led to the Diagnosis of Uterine Fibroids A 44-Year-Old Woman’s Treatment Experience Uterine fibroids are a common health condition among women, but symptoms are not always obvious and may be overlooked. Ms. Wang (pseudonym), a 44-year-old patient, is one such case. Her experience reflects the clinical course faced by many women with uterine fibroids. She reported that starting in October 2025, she experienced a significant increase in menstrual bleeding accompanied by blood clots, which gradually affected her daily life. After medical evaluation by Dr. Liu, suspected endometrial abnormalities were identified, and further treatment was recommended. After discussing treatment options with her physician, Ms. Wang underwent a da Vinci Single-Port (SP) hysterectomy with bilateral salpingectomy in November 2025. The procedure was performed through a single incision of approximately 2.5 cm using the da Vinci SP system. After surgery, Ms. Wang shared that she experienced little postoperative discomfort, and the surgical scar on her abdomen was not easily noticeable. She was later invited to share her treatment experience during activities held at the Gynecologic da Vinci Single-Port Surgery Observation Center, providing insight into real-world clinical cases. figure data-wp-context="{"uploadedSrc":"https:\/\/tconf.sltung.com.tw\/imc\/wp-content\/uploads\/sites\/2\/2026\/01\/da-vinci-sp-uterine-fibroid-patient-story-tungs-hospital-1.jpg","figureClassNames":"wp-block-image aligncenter size-full","figureStyles":null,"imgClassNames":"wp-image-10267","imgStyles":null,"targetWidth":940,"targetHeight":788,"scaleAttr":false,"ariaLabel":"Enlarge image: 44y Patient Shares Her da Vinci Single-Port (SP) Gynecologic Surgery Experience","alt":"44y Patient Shares Her da Vinci Single-Port (SP) Gynecologic Surgery Experience"}" data-wp-interactive="core/image" class="wp-block-image aligncenter size-full wp-lightbox-container" style="box-sizing: inherit; margin: 0px auto; border: 0px; font-style: inherit; font-weight: inherit; outline: 0px; padding: 0px; vertical-align: baseline; clear: both; text-align: center; display: table; flex-direction: column; position: relative; width: 796px; min-width: unset !important;">svg xmlns="http://www.w3.org/2000/svg" width="12" height="12" fill="none" viewbox=""> path fill="#fff" d="M2 0a2 2 0 0 0-2 2v2h1.5V2a.5.5 0 0 1 .5-.5h2V0H2Zm2 10.5H2a.5.5 0 0 1-.5-.5V8H0v2a2 2 0 0 0 2 2h2v-1.5ZM8 12v-1.5h2a.5.5 0 0 0 .5-.5V8H12v2a2 2 0 0 1-2 2H8Zm2-12a2 2 0 0 1 2 2v2h-1.5V2a.5.5 0 0 0-.5-.5H8V0h2Z">/path> /svg>figcaption class="wp-element-caption" style="box-sizing: inherit; margin-bottom: 1em; margin-top: 0.5em; caption-side: bottom; display: table-caption;">da-vinci-sp-uterine-fibroid-patient-story-tungs-hospital/figcaption>/figure> Understanding Uterine Fibroids What Are Uterine Fibroids? Uterine fibroids are benign tumors formed by the abnormal growth of uterine smooth muscle cells. Simply put, they are muscle lumps that develop in the uterus. The exact cause of uterine fibroids is not fully understood. However, studies suggest that several factors may be associated with their development: Hormonal Factors (Estrogen and Progesterone) Uterine fibroids are more common in women of reproductive age and are closely related to female hormone levels. Estrogen and progesterone may promote the growth of uterine muscle cells and contribute to fibroid enlargement. Genetic Predisposition Women with a family history of uterine fibroids, such as a mother or sister with the condition, may have a higher likelihood of developing fibroids, suggesting a genetic component. Abnormal Growth of Uterine Smooth Muscle Cells Uterine fibroids result from abnormal proliferation of uterine smooth muscle cells. Changes in cell growth regulation may gradually lead to fibroid formation. Age and Reproductive Factors Uterine fibroids are most commonly seen in women aged30 to 50, and are more frequently observed in women who have had fewer or no pregnancies. It is important to note thatuterine fibroids are not caused by poor lifestyle habits and are not cancerous. Most fibroids are benign, and whether treatment is needed should be evaluated by a physician based on symptoms, size, and location. Do Uterine Fibroids Always Cause Symptoms? Not necessarily. Some women have uterine fibroids without experiencing any noticeable discomfort, while others may have symptoms such as: Heavier menstrual bleeding or longer periods Blood clots during menstruation A feeling of pressure or discomfort in the lower abdomen Frequent urination or a sense of abdominal pressure Chronic pelvic pain Whether symptoms occur often depends on thesize, location, and numberof the fibroids. If these symptoms are present, consultation with a gynecologist is recommended. Do Uterine Fibroids Always Require Treatment? Not all uterine fibroids require immediate treatment. Management options may include observation, medication, or surgery. The decision to proceed with treatment is usually based on several factors, including: Whether symptoms affect daily life The size and growth of the fibroids The location of the fibroids Age and overall health condition For patients with significant symptoms or associated conditions, physicians may recommend further treatment after thorough discussion. figure data-wp-context="{"uploadedSrc":"https:\/\/tconf.sltung.com.tw\/imc\/wp-content\/uploads\/sites\/2\/2026\/01\/what-are-uterine-fibroids-symptoms-treatment-1.jpg","figureClassNames":"wp-block-image aligncenter size-full","figureStyles":null,"imgClassNames":"wp-image-10268","imgStyles":null,"targetWidth":940,"targetHeight":788,"scaleAttr":false,"ariaLabel":"Enlarge image: what-are-uterine-fibroids-symptoms-treatment","alt":"what-are-uterine-fibroids-symptoms-treatment"}" data-wp-interactive="core/image" class="wp-block-image aligncenter size-full wp-lightbox-container" style="box-sizing: inherit; margin: 0px auto; border: 0px; font-style: inherit; font-weight: inherit; outline: 0px; padding: 0px; vertical-align: baseline; clear: both; text-align: center; display: table; flex-direction: column; position: relative; width: 796px; min-width: unset !important;">svg xmlns="http://www.w3.org/2000/svg" width="12" height="12" fill="none" viewbox=""> path fill="#fff" d="M2 0a2 2 0 0 0-2 2v2h1.5V2a.5.5 0 0 1 .5-.5h2V0H2Zm2 10.5H2a.5.5 0 0 1-.5-.5V8H0v2a2 2 0 0 0 2 2h2v-1.5ZM8 12v-1.5h2a.5.5 0 0 0 .5-.5V8H12v2a2 2 0 0 1-2 2H8Zm2-12a2 2 0 0 1 2 2v2h-1.5V2a.5.5 0 0 0-.5-.5H8V0h2Z">/path> /svg>figcaption class="wp-element-caption" style="box-sizing: inherit; margin-bottom: 1em; margin-top: 0.5em; caption-side: bottom; display: table-caption;">what-are-uterine-fibroids-symptoms-treatment/figcaption>/figure> One Incision, Supporting Women Through Their Treatment Journey Through real patient experiences and clinical exchange, Tungs’ Hospital aims to help women better understand their health conditions and engage in informed discussions with physicians when considering treatment options for uterine fibroids and other gynecologic conditions. Women experiencing abnormal menstrual bleeding or pelvic discomfort are encouraged to consult a gynecologist for evaluation. Consult Now If you would like to consult with FORMOSA TUNGS+ IMedS Message us on WhatsApp, and our coordinator will contact you asap WhatsApp Social Media FORMOSA TUNGS+ IMedS is on various social media platforms Updating the newest medical insights and stories! View Page

    #Robotic Surgery#Health Screening#Medical Tourism
  • 【Tungs Hospital】Global Leaders Gather at TICS-2025 — Experts from Eight Nations Unites to Advance Urology

    【Tungs Hospital】Global Leaders Gather at TICS-2025 — Experts from Eight Nations Unites to Advance Urology

    Global Leaders Gather at TICS-2025 — Tungs’ Taichung MetroHarbor Hospital Unites Experts from Eight Nations to Advance Urology Tungs’ Taichung MetroHarbor Hospital is committed to excellence, continuously adopting the latest international medical technologies while bringing cutting-edge innovations and advanced medical equipment to Taiwan. Through this effort, we aim to empower Taiwan’s medical community—both senior and emerging professionals—to elevate clinical skills and knowledge, ultimately delivering world-class medical care to every patient. This year, Tungs’ Taichung MetroHarbor Hospital co-hosts theTICS-2025 International Urology Conferencewith the Taiwan Innovative Clinical Society (TICS), Taiwan Urological Association, Taiwan Association of Nurse Practitioners, Tung Chuan-Sheng Education Foundation, Taiwan Urologic Oncology Association, and the College of Life Sciences at National Chung Hsing University. The conference will be held onNovember 21–22, with theTICS-2025 Launch Press Conferencetaking place today (November 19). The event was attended by Tungs’ ChairmanDr. Min-Che Tung, R&D and Innovation Center DirectorDr. Yen-Chuan Ou, UrologistDr. Chang-Ho Chiang, and Nursing DirectorSupervisor Shih-Ping Tseng, alongside distinguished guests including: Dr. Tzu-Ping Lin, Deputy Director of Surgery, Kaohsiung Veterans General Hospital Dr. Cheng-Hsi Liao, Director, Center for Health Promotion & Management and Outpatient Services, Taichung Armed Forces General Hospital Mr. Chi-Sheng Yang, Vice President & General Manager, Intuitive Surgical Taiwan figure data-wp-context="{"uploadedSrc":"https:\/\/tconf.sltung.com.tw\/imc\/wp-content\/uploads\/sites\/2\/2025\/12\/TICS-2025\u6ccc\u5c3f\u91ab\u5b78\u570b\u969b\u7814\u8a0e\u6703\u5c07\u65bc1121\u82071122\u5169\u65e5\u767b\u5834-1.webp","figureClassNames":"wp-block-image aligncenter size-full","figureStyles":null,"imgClassNames":"wp-image-9550","imgStyles":null,"targetWidth":960,"targetHeight":540,"scaleAttr":false,"ariaLabel":"Enlarge image: The conference will be held on November 21\u201322, with the TICS-2025 Launch Press Conference taking place today (November 19)","alt":"The conference will be held on November 21\u201322, with the TICS-2025 Launch Press Conference taking place today (November 19)"}" data-wp-interactive="core/image" class="wp-block-image aligncenter size-full wp-lightbox-container" style="box-sizing: inherit; margin: 0px auto; border: 0px; font-style: inherit; font-weight: inherit; outline: 0px; padding: 0px; vertical-align: baseline; clear: both; text-align: center; display: table; flex-direction: column; position: relative; width: 796px; min-width: unset !important;">svg xmlns="http://www.w3.org/2000/svg" width="12" height="12" fill="none" viewbox=""> path fill="#fff" d="M2 0a2 2 0 0 0-2 2v2h1.5V2a.5.5 0 0 1 .5-.5h2V0H2Zm2 10.5H2a.5.5 0 0 1-.5-.5V8H0v2a2 2 0 0 0 2 2h2v-1.5ZM8 12v-1.5h2a.5.5 0 0 0 .5-.5V8H12v2a2 2 0 0 1-2 2H8Zm2-12a2 2 0 0 1 2 2v2h-1.5V2a.5.5 0 0 0-.5-.5H8V0h2Z">/path> /svg>figcaption class="wp-element-caption" style="box-sizing: inherit; margin-bottom: 1em; margin-top: 0.5em; caption-side: bottom; display: table-caption;">The conference will be held on November 21–22, with the TICS-2025 Launch Press Conference taking place today (November 19)/figcaption>/figure> Da Vinci SP Urology Observation Center Certification During the event, Mr. Chi-Sheng Yang of Intuitive Surgical formally presented a plaque certifying Tungs’ Hospital as an officialDa Vinci SP Urology Observation Center, recognizing Dr. Yen-Chuan Ou as Taiwan’sfirst certified proctorfor Da Vinci SP urological surgery training. Since introducing the newestDa Vinci Single-Port (SP) Robotic Systemon May 23, Dr. Ou became the first in Taiwan to complete a SP radical prostatectomy. To date, Tungs’ Hospital has completed250 SP robotic procedures, with Dr. Ou performing more than50 successful cases, offering patients the benefits of minimal incisions, faster recovery, and improved quality of life. Commitment from Intuitive Surgical Mr. Chi-Sheng Yang emphasized that physician training is the core of medical innovation. Beyond providing the Da Vinci surgical system, Intuitive actively builds a comprehensive training ecosystem—simulation, clinical observation, and proctor development—to ensure surgeons worldwide can deliver optimal patient outcomes. He expressed honor in welcoming Tungs’ Hospital as a key training hub within this global ecosystem. TICS-2025: GLOBAL CONNECTION — A New Era of Urology Dr. Yen-Chuan Ou, Co-Chair of TICS-2025, shared that this year’s theme,“Global Connection,”continues the foundation built in TICS-2024. The conference brings together leading experts fromthe United States, Korea, Japan, Singapore, India, the United Kingdom, and France, fostering international academic exchange. The conference focuses on“The New Era of Urology: Innovation · Precision · Integration”, highlighting future development in: Innovative surgical technologies Precision medicine Cross-disciplinary integration Evolving diagnostic and treatment models figure data-wp-context="{"uploadedSrc":"https:\/\/tconf.sltung.com.tw\/imc\/wp-content\/uploads\/sites\/2\/2025\/12\/\u6b50\u5bb4\u6cc9\u9662\u9577\u6210\u70ba\u7387\u5148\u53d6\u5f97\u300c\u6ccc\u5c3f\u79d1\u9054\u6587\u897fSP\u624b\u8853\u89c0\u6469\u4e2d\u5fc3\u300d\u6307\u5c0e\u8001\u5e2b\u8cc7\u683c\uff0c\u7531\u76f4\u89ba\u516c\u53f8\u694a\u7e7c\u76db\u526f\u7e3d\u88c1\u9812\u8d08\u6ccc\u5c3f\u9054\u6587\u897fSP\u89c0\u6469\u4e2d\u5fc3\u734e\u724c-1.webp","figureClassNames":"wp-block-image aligncenter size-full","figureStyles":null,"imgClassNames":"wp-image-9551","imgStyles":null,"targetWidth":960,"targetHeight":640,"scaleAttr":false,"ariaLabel":"Enlarge image: Da Vinci SP Urology Observation Center Certification","alt":"Da Vinci SP Urology Observation Center Certification"}" data-wp-interactive="core/image" class="wp-block-image aligncenter size-full wp-lightbox-container" style="box-sizing: inherit; margin: 0px auto; border: 0px; font-style: inherit; font-weight: inherit; outline: 0px; padding: 0px; vertical-align: baseline; clear: both; text-align: center; display: table; flex-direction: column; position: relative; width: 796px; min-width: unset !important;">svg xmlns="http://www.w3.org/2000/svg" width="12" height="12" fill="none" viewbox=""> path fill="#fff" d="M2 0a2 2 0 0 0-2 2v2h1.5V2a.5.5 0 0 1 .5-.5h2V0H2Zm2 10.5H2a.5.5 0 0 1-.5-.5V8H0v2a2 2 0 0 0 2 2h2v-1.5ZM8 12v-1.5h2a.5.5 0 0 0 .5-.5V8H12v2a2 2 0 0 1-2 2H8Zm2-12a2 2 0 0 1 2 2v2h-1.5V2a.5.5 0 0 0-.5-.5H8V0h2Z">/path> /svg>figcaption class="wp-element-caption" style="box-sizing: inherit; margin-bottom: 1em; margin-top: 0.5em; caption-side: bottom; display: table-caption;">Da Vinci SP Urology Observation Center Certification/figcaption>/figure> Key Highlights of TICS-2025 Live Surgery Demonstrations Da Vinci SP radical prostatectomy at Tungs’ International surgical experience sharing (U.S., Japan, Korea) Urology AI & Big Data Applications Predictive analytics Clinical decision support Smart healthcare platforms Cutting-edge Treatment Innovations New therapies for urologic diseases Robotics & minimally invasive advancements Nursing Excellence in Robotic Surgery To ensure optimal patient safety, international experts will share best practices in robotic nursing, instrument handling, high-tech robotic OR beds, and surgical pressure-injury prevention—aiming to shorten learning curves in robotic team training. Building a Global Academic Platform The conference also explores the integration of next-generation AI and big data to improve clinical outcomes and enhance care efficiency. Through cross-border collaboration and sharing of research advancements, TICS-2025 aims to open new chapters in urologic medicine worldwide. A Message from the Conference Chair Dr. Min-Che Tung, Chairman of Tungs’ Hospital and Chair of TICS-2025, emphasized that the TICS conference—now in its third year—has become a major platform for global leaders to exchange insights, share breakthroughs, and shape the future of clinical practice. The conference strives to: Promote global exchange Drive medical innovation Strengthen precision medicine Foster cross-disciplinary integration Cultivate the next generation of medical talent Source:https://tw.news.yahoo.com/share/76e4956e-ab8b-38b8-9b7c-89652621faca

    #Assisted Reproductive Technology#Health Screening#Medical Tourism
  • 【Tungs' Hospital】 Tungs’ Hospital Achieves Over 100 Da Vinci SP Robotic Surgeries | Established International Training Center

    【Tungs' Hospital】 Tungs’ Hospital Achieves Over 100 Da Vinci SP Robotic Surgeries | Established International Training Center

    article class="post-9508 post type-post status-publish format-standard has-post-thumbnail hentry category-casestory-en category-news-and-events-en category-medical-news-and-update-en tag-da-vinci-sp tag-minimally-invasive-surgery tag-robotic-surgery ast-article-single" id="post-9508" itemtype="https://schema.org/CreativeWork" itemscope="itemscope" style="box-sizing: inherit; margin: 0px 0px 2em; padding-bottom: 2em; padding-left: 1em; padding-right: 1em; color: rgb(46, 56, 85); font-family: "Source Sans 3", sans-serif; font-size: 17px;">/article> article class="post-9508 post type-post status-publish format-standard has-post-thumbnail hentry category-casestory-en category-news-and-events-en category-medical-news-and-update-en tag-da-vinci-sp tag-minimally-invasive-surgery tag-robotic-surgery ast-article-single" id="post-9508" itemtype="https://schema.org/CreativeWork" itemscope="itemscope" style="box-sizing: inherit; margin: 0px 0px 2em; padding-bottom: 2em; padding-left: 1em; padding-right: 1em; color: rgb(46, 56, 85); font-family: "Source Sans 3", sans-serif; font-size: 17px;"> figure class="wp-block-image aligncenter size-large" style="box-sizing: inherit; margin: 0px auto; border: 0px; font-style: inherit; font-weight: inherit; outline: 0px; padding: 0px; vertical-align: baseline; clear: both; text-align: center; display: table; width: 775.762px; position: relative; min-width: unset !important;">figcaption class="wp-element-caption" style="box-sizing: inherit; margin-bottom: 1em; margin-top: 0.5em; caption-side: bottom; display: table-caption;">Let Tungs lend a hand Da Vinci SP robotic surgery/figcaption>/figure> Tungs’ Taichung MetroHarbor Hospital held a press conference titled“Technology Leads, Innovation Achieves — Da Vinci SP Robotic Surgery Surpasses 100 Cases”. The event brought together multidisciplinary medical teams from Gynecology, Urology, ENT, Thoracic Surgery, Transplantation, and General Surgery, along with patients who had successfully undergone Da Vinci SP (Single Port) robotic surgeries. They shared their recovery experiences, allowing the public to witness how advanced medical technology is transforming lives. During the event,Dr. Yen-Chuan Ou, Dean of the Research and Innovation Center, demonstrated the latestDa Vinci SP robotic surgical system, providing attendees with a close-up view of its cutting-edge precision. Dr. Ou also announced the establishment of theInternational Education and Observation Center for Single-Port Robotic Surgery, which will serve as a global platform for clinical education and surgical observation. Through professional training for domestic and international surgeons and cross-border knowledge exchange, Tungs’ aims to position Taiwan as an international training hub for single-port minimally invasive surgery—bringing renewed hope and high-quality care to patients worldwide. Over 130 Successful SP Surgeries in Just Three Months figure class="wp-block-image aligncenter size-large" style="box-sizing: inherit; margin: 0px auto; border: 0px; font-style: inherit; font-weight: inherit; outline: 0px; padding: 0px; vertical-align: baseline; clear: both; text-align: center; display: table; width: 775.762px; position: relative; min-width: unset !important;">figcaption class="wp-element-caption" style="box-sizing: inherit; margin-bottom: 1em; margin-top: 0.5em; caption-side: bottom; display: table-caption;">Over 130 Successful SP Surgeries in Just Three Months/figcaption>/figure> Dr. Ou shared that the hospital introduced the latestDa Vinci SP surgical systemon May 23, 2025, and he personally performed the hospital’s first robotic prostatectomy on the same day. Since then, the Urology, Gynecology, ENT, General Surgery, and Thoracic Surgery departments have successfully completed130 SP procedures by August 31, marking a major clinical achievement. This innovative single-incision approach minimizes pain, speeds up recovery, and improves post-operative quality of life. Future applications will expand into Cardiac Surgery, Colorectal Surgery, and Pediatric Surgery—forming a multidisciplinary platform for integrated robotic single-port techniques. Transformative Patient Stories figure class="wp-block-image aligncenter size-large" style="box-sizing: inherit; margin: 0px auto; border: 0px; font-style: inherit; font-weight: inherit; outline: 0px; padding: 0px; vertical-align: baseline; clear: both; text-align: center; display: table; width: 775.762px; position: relative; min-width: unset !important;">figcaption class="wp-element-caption" style="box-sizing: inherit; margin-bottom: 1em; margin-top: 0.5em; caption-side: bottom; display: table-caption;">83y Mr. Chen undergo Da Vinci SP robotic prostatectomy/figcaption>/figure> 86-year-old Mr. Chen, an active motorcyclist and participant of the “Evergreen Riders” charity tour, was diagnosed with prostate cancer (PSA 13.18 ng/mL). After undergoing Da Vinci SP robotic prostatectomy, he was able to eat and shower the next day, discharged on day three, and showed no need for suture removal. Now fully recovered, he even performed saxophone music at the press event, demonstrating his vitality. 67-year-old Mr. Linwas diagnosed with squamous cell carcinoma of the right soft palate and a uvular tumor.Vice Superintendent Dr. Ching-Shao Tsaiperformed transoral Da Vinci SP robotic surgery to precisely remove both lesions, preserving oral function and ensuring a rapid recovery. 34-year-old Ms. Fansuffered from heavy menstruation and urinary frequency caused by a uterine fibroid compressing her bladder.Dr. Chin-Cheng Liu, Director of Gynecology, performed SP robotic myomectomy via a single small incision, completely removing the fibroid while preserving uterine integrity—allowing the patient to retain fertility potential. 35-year-old Ms. Pengexperienced chronic lower abdominal pain.Dr. Chun-Cheng Hsu, Director of Gynecologic Endoscopy, diagnosed bilateral ovarian endometriomas and pelvic endometriosis. She underwent natural orifice SP robotic excision surgery with no visible abdominal scars and rapid recovery—marking a true “new beginning” for her health. 70-year-old Mr. Hsiehpresented with painless hematuria and urinary obstruction, diagnosed as right renal pelvic carcinoma. Considering prior esophageal surgery and the risk of adhesions,Dr. Wei-Chun Weng, Director of Urologic Endoscopy, performed an extraperitoneal SP robotic nephroureterectomy. The tumor was completely removed with only one small incision, and the patient walked the next day and was discharged on day three. 22-year-old Ms. Chenwas found to have right thyroid nodules causing neck compression and breathing difficulty.Dr. Chi-Kun Yu, Director of General Surgery, performed a scarless transaxillary SP robotic thyroidectomy. Under 3D magnified vision, nerves and parathyroid glands were precisely identified and preserved. The patient was discharged on postoperative day three with excellent recovery. These cases embody the key advantages of single-port robotic surgery—smaller incisions, less pain, faster recovery, and improved quality of life. A Vision for International Excellence figure class="wp-block-image aligncenter size-large" style="box-sizing: inherit; margin: 0px auto; border: 0px; font-style: inherit; font-weight: inherit; outline: 0px; padding: 0px; vertical-align: baseline; clear: both; text-align: center; display: table; width: 377.871px; position: relative; min-width: unset !important;">figcaption class="wp-element-caption" style="box-sizing: inherit; margin-bottom: 1em; margin-top: 0.5em; caption-side: bottom; display: table-caption;">Dr. Yen-Chuan Ou Performing Da Vinci SP Robotic System/figcaption>/figure>figure class="wp-block-image aligncenter size-large" style="box-sizing: inherit; margin: 0px auto; border: 0px; font-style: inherit; font-weight: inherit; outline: 0px; padding: 0px; vertical-align: baseline; clear: both; text-align: center; display: table; width: 377.871px; position: relative; min-width: unset !important;">figcaption class="wp-element-caption" style="box-sizing: inherit; margin-bottom: 1em; margin-top: 0.5em; caption-side: bottom; display: table-caption;">Exhibiting Da Vinci SP System Operating On a 55*45*45mm small toy/figcaption>/figure> Superintendent Dr. Min-Che Tungemphasized that the hospital has always adhered to a“patient-centered”philosophy, continuously introducing state-of-the-art medical technologies to enhance precision and innovation. Completing130 SP robotic surgeries in just over three monthsdemonstrates not only the hospital’s strong surgical capabilities but also Taiwan’s pioneering spirit in medical innovation and its alignment with global standards. Tungs’ Taichung MetroHarbor Hospital will continue its mission to become“the most trusted hospital among global citizens,”providing world-class surgical treatments and renewed hope for patients around the world. figure class="wp-block-image aligncenter size-large" style="box-sizing: inherit; margin: 0px auto; border: 0px; font-style: inherit; font-weight: inherit; outline: 0px; padding: 0px; vertical-align: baseline; clear: both; text-align: center; display: table; width: 775.762px; position: relative; min-width: unset !important;">figcaption class="wp-element-caption" style="box-sizing: inherit; margin-bottom: 1em; margin-top: 0.5em; caption-side: bottom; display: table-caption;">Tungs’ Hospital is the first hospital to introduce Da Vinci SP in Taiwan/figcaption>/figure> Follow us on Social Media FORMOSA TUNGS+ IMedS is on various social media platforms Updating the newest medical insights and stories! View Page Consult Now If you would like to consult with FORMOSA TUNGS+ IMedS Click on the button below to view contact! Contact IMedS /article> nav class="navigation post-navigation" role="navigation" aria-label="Post navigation" style="box-sizing: inherit; margin: 0px; overflow: hidden; padding: 2em 0px 0px; border-top: 1.25px solid rgb(178, 180, 189); color: rgb(46, 56, 85); font-family: "Source Sans 3", sans-serif; font-size: 17px;">Post/nav>

    #Assisted Reproductive Technology#Cardiovascular Surgery#Cancer Treatment#Robotic Surgery#Liver Transplantation#Medical Tourism
  • 40 Years Old, With One "Low Mosaic Embryo", One Try, One Success: The Ultimate NUWA Fertility IVF Success Story!

    40 Years Old, With One "Low Mosaic Embryo", One Try, One Success: The Ultimate NUWA Fertility IVF Success Story!

    At 40 years old, she carried more than just the hope to start her own family. Despite having frozen embryos remaining, the scars of those two previous IVF failures loomed large, casting a shadow over her hope. With great encouragement from her family and friends, she found the courage again and began traveling from Kaohsiung to the NUWA Fertility Center in Taichung, searching for a glimmer of new hope. During her first consultation, Dr. Huai-Ling Wang personally conducted a comprehensive evaluation. After meticulously reviewing every detail, he tailored a special medical treatment plan specifically for this couple. This strategic approach successfully retrieved 15 mature eggs, which developed into 3 healthy embryos. Following the PGT-A (PGS) chromosomal screening test, the report showed that 2 of the 3 embryos were mosaic, presenting a clinical challenge they would have to navigate together. Can a mosaic embryo result in a successful pregnancy? Facing the news of "mosaic embryos," the couple initially felt a sense of uncertainty. However, through detailed clinical consultation, they learned that these embryos are not failures. A mosaic embryo still contains both normal and abnormal chromosomes. In a wonderful turn of events, the embryo implanted successfully! The pregnancy remained stable, and the expectant mother has now officially "graduated" at her 10 weeks of pregnancy, ready to welcome her very own little miracle. Maximizing pregnancy potential: Understanding mosaic embryos. The critical role of chromosomal health in IVF success. Following a thorough consultation, the couple chose to proceed with the “low mosaic embryo”. They were encouraged by the fact that this embryo still held a high potential to develop into a healthy baby and had the ability to self-repair during development. For parents-to-be, this is a viable option to consider for a successful pregnancy. Always, of course, with the guidance and approval of your physician. Throughout this journey, the couple felt deeply supported by the unwavering professionalism and care from NUWA medical team. Every conversation and every tiny adjustment to their treatment plan was a move toward success.This couple's story proves that even with just one embryo, miracles are possible. NUWA Fertility team refuses to give up on even the smallest glimmer of hope, believing that every moment of hard work can eventually bloom into a lifetime of joy. Read More: ����What is IVF? Understanding the process, costs, and success rates ����NUWA Fertility Center Services ����What is PGS/PGT-A? Who should receive PGS/PGT-A screening?

    #Assisted Reproductive Technology
  • NUWA Success Story: Overcome Azoospermia, success pregnancy in 1 try with Sperm Donor & IVF!

    NUWA Success Story: Overcome Azoospermia, success pregnancy in 1 try with Sperm Donor & IVF!

    For many couples, the journey to parenthood is filled with ups and downs. When the husband is diagnosed with Azoospermia (a condition where there is no sperm alive inside the semen), natural pregnancy is not an option for this couple. Another option available is looking for a Sperm Donor. An unknown journey that requires choosing the right professional medical team! This was a journey of a couple who attempted doing multiple IVF cycles with sperm donor treatments at other clinics without success. By chance, they attended a seminar held by NUWA Fertility Center, and decided to give themselves one last chance to try, and surprisingly they achieved a successful pregnancy at NUWA with just their 1st try! A Success Story of Sperm Donor with IVF: Even with Azoospermia, Pregnancy is Possible. The road to pregnancy is often fraught with challenges, particularly for couples facing with male infertility and the subsequent need for a sperm donor. A path frequently paved with uncertainty, yet also with incredible strength. Take this one remarkable couple, for instance. After enduring numerous disappointments, they made the courageous decision to trust NUWA. Through a carefully designed and compassionate donor sperm program, they found not just a solution, but a supportive partner every step of the way. Now, they are celebrating the miracle they once thought impossible. NUWA Fertility Sperm Donor Service: Taiwan Larger Sperm Bank Service for Quick Matching System for couples in need. To support couples in need, NUWA Fertility Center offers a comprehensive Sperm Donor Service equipped with an extensive sperm bank option. Quick matching process and able to shorten any waiting time. A huge advantage for couples running with time, make every second count! Back to the story: after a thorough discussion with their doctor, the couple decided to proceed with the spermdonor procedure at NUWA. Unlike the long waiting periods experienced in other clinics, the process at NUWA Fertility Center started immediately, helping the couple to take that crucial time, the first step toward the pregnancy. Adjusting the Protocol: Success on the First Sperm Donor & IVF cycle. Early in the treatment, the wife’s AMH levels (ovarian reserve)dropped unexpectedly, and the first egg retrieval results were not ideal. But NUWA’s medical team did not give up. Instead, they completely readjusted the medication strategy based on her physical condition. Under the careful planning from Dr. Shen Tzu Yu, the next cycle the wife successfully retrieved 15 mature eggs! Through healthy diet and lifestyle adjustments, the embryo quality improved significantly. The miracle happened on the first transfer! A Happy Graduation! On the day the couple received their "Pregnancy Graduation Certificate," their joy was overflowing. Filled with happiness, they are now ready to welcome a new life into the world. If you are wondering where you should go looking for a Sperm Donor Service combined with the best expertise and newest technology? NUWA Fertility is your answer! Many couples ask: "Is the sperm donor process the same everywhere?" The answer is: No, it is not! The success of a Sperm Donor with IVF cycle depends on more than just finding a donor. It requires: ✅ Professional infertility diagnostic strategies. ✅ Advanced embryo laboratory technology. ✅ Personalized treatment planning. ✅ A high resource with larger sperm bank for fast matching system. NUWA Fertility Center does not just provide sperm donor services! But also provide a team of expert physicians with advanced lab technology! ����NUWA Fertility Center - Male and Female Infertility Examination Introduction ����NUWA Fertility Center - IVF Service ����NUWA Fertility Center - Egg Donor Service ����NUWA Fertility Center - Sperm Donor Service

    #Assisted Reproductive Technology
  • IVF Success at 42: A Story of Resilience and Joy

    IVF Success at 42: A Story of Resilience and Joy

    At 42 years and 3 months young. Finally, the miracle is here! After years of trying, she achieved success on her very first IVF cycle here at Nuwa Fertility! Three years ago, the couple underwent two rounds of egg retrieval and embryo transfer at a well-known fertility center in Linkou. Despite their resilience, those attempts didn’t lead to the result they dreamed of. Read More: ����Your Path to Parenthood: A Comprehensive Guide to the IVF Process Seeking a second chance: Traveling from Linkou to Nuwa Taipei Fertility Center They came to NUWA through a referral. This couple’s journey was paved with both trust and past heartbreak. The drive from Linkou is never easy, often a battle against heavy traffic, but their unwavering dedication touched the hearts of the entire NUWA medical team. Recognizing that their previous specialists were also top-tier experts, this led to a critical realization: "If the previous doctors were excellent, what missing piece of the puzzle was overlooked?" Dr. Lin knew the answer wouldn't be found that easily. He meticulously observed, compared every detail, and connected all the clues. Finally, he designed a fully "customized IVF plan" tailored specifically for them. Read More: ���� What is IVF? Understanding the process, costs, and success rates Precision Meets Joy: One Retrieval, One Transfer, One Success. ✨ One egg retrieval yielded 5 PGS-normal blastocysts. ✨ The first single-embryo transfer resulted in successful implantation and a stable pregnancy. ✨ NIPT follow-up report came back completely normal. Their incredible dedication has finally turned their long-awaited dream into a joyful reality. Behind this joyful miracle lies a solid foundation of strategy. The result of NUWA doctor and the team's meticulous evaluation, customized treatment plan, and great strategy. Nuwa team is deeply grateful to this couple for their big trust and for their incredible persistence. Give thanks for this beautiful blessing! Read More: ���� About NUWA Fertility Center Services ����What is PGS/PGT-A? Who should receive PGS/PGT-A screening?

    #Assisted Reproductive Technology
  • 【Tungs Hospital】Halcyon™: Treat & Monitor | Cancer Radiotherapy

    【Tungs Hospital】Halcyon™: Treat & Monitor | Cancer Radiotherapy

    Mr. Ramon from the Philippines was diagnosed with stage IV lung cancer years ago, with metastasis to the bones that caused him to endure severe spinal pain over a long period of time. On a friend’s recommendation, he decided to come to Taiwan for radiotherapy. Upon arrival, Mr. Ramon relied on a wheelchair, assisted by airline staff at Taoyuan International Airport, and was then transferred to our hospital by shuttle service for admission and treatment. After receiving Halcyon™ radiotherapy, his condition improved significantly; by the time of discharge, he was able to walk independently without the need for a wheelchair. Even after returning home, both his pain and cancer progression have remained under control. Dr. Chih-Yuan Yeh, Director of the Department of Radiation Oncology at Tungs’ Hospital, emphasized that radiotherapy plays a crucial role in cancer treatment, commonly used to shrink tumors, kill cancer cells, and relieve symptoms. A single course of radiotherapy may take several weeks and involve dozens of sessions. During this period, the tumor itself may change in size or position due to treatment. Without timely monitoring and adjustment of the treatment plan, such changes could lead to dosage inaccuracies, affecting both the effectiveness of the therapy and the safety of surrounding healthy tissues. Hypersight Navigation Speeds Up Positioning and Enables Precise Adaptive Radiotherapy In the past, radiotherapy positioning relied on conventional image guidance, which was often limited by insufficient image resolution and lengthy processing times, restricting the ability to make real-time adjustments. The newly introduced Halcyon™ system, equipped with Hypersight technology, can capture cone-beam CT images in just six seconds and directly calculate dosage on the images. With image quality comparable to diagnostic CT scans and a field of view covering the entire tumor region and surrounding critical organs, it helps physicians assess patient positioning, tumor location, and volume changes—greatly enhancing treatment accuracy. This technology also advances the practice ofAdaptive Radiotherapy. Dr. Chih-Yuan Yeh explained that this approach allows physicians to fine-tune treatment parameters based on the patient’s daily condition, transforming radiotherapy from a single fixed plan into a dynamic, real-time adjusted process—achieving truly precise and personalized care. Dr. Chia-Hua Yen, attending physician in the Department of Radiation Oncology, added that for cancers such as prostate cancer, where tumors are located near the bladder and rectum, their position may shift due to urination or weight changes. Halcyon’s combination of rapid navigation and adjustment capabilities can correct these shifts in real time, preventing dosage errors, improving treatment effectiveness, and reducing the risk of side effects. Dr. Chia-Hua Yen, attending physician in the Department of Radiation Oncology, added that for cancers such as prostate cancer, where tumors are located near the bladder and rectum, their position may shift due to urination or weight changes. Halcyon’s combination of rapid navigation and adjustment capabilities can correct these shifts in real time, preventing dosage errors, improving treatment effectiveness, and reducing the risk of side effects. Clinical Case Highlights: Tumor Shrinkage Increases Chance of Cure Patients at Tungs’ Hospital have already benefited from this advanced technology. One 57-year-old patient was diagnosed with stage I oral cancer in 2024. Although surgery initially went well, later that year a 0.5 cm tumor reappeared on the lip, followed by a large tumor of about 350 cubic centimeters extending from the cheek to the shoulder and neck. Because of the tumor’s size and the high surgical risk, the medical team decided to begin treatment with Halcyon™ radiotherapy. Over the course of one and a half months, the patient underwent 35 radiotherapy sessions, with Hypersight imaging scans performed daily to monitor tumor size and positioning. By the end of treatment, the tumor volume had shrunk from 350 cc to around 200 cc. This allowed the patient to successfully continue with chemotherapy and surgery, significantly improving the likelihood of complete tumor removal. Dr. Chih-Yuan Yeh noted that despite the intensive regimen, the patient tolerated treatment well, showing how new technology can boost both treatment tolerance and patient confidence. Precision and Real-Time Benefits: Helping Patients with Metastatic Disease Dr. Yeh further explained that Halcyon™ is suitable for a wide range of cancers, offering particular advantages for patients with widespread or complex tumors. For example, patients with multiple lung metastases were once considered unsuitable for radiotherapy. Today, by combining Halcyon™ with stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT), multiple lesions can be treated safely and precisely with high doses. He also cited international clinical research showing that patients with nasopharyngeal and head and neck cancers who received adaptive radiotherapy achieved a 10% higher 5-year survival rate. To date, more than 200 patients have received high-quality treatment using the Halcyon™ system at Tungs’ Hospital. President Min-Che Tung emphasized that precision and timeliness are at the core of cancer treatment. The introduction of Halcyon™ demonstrates the hospital’s commitment to patient health and reflects its mission to use innovative technology and quality care to guide more cancer patients toward recovery.

    #Cancer Treatment
  • [Taiwan–Malaysia Medical Innovation Forum] CMUH and UNIMAS Co-Host Major Medical Symposium to Advance Medical Technology and Precision Patient Care

    [Taiwan–Malaysia Medical Innovation Forum] CMUH and UNIMAS Co-Host Major Medical Symposium to Advance Medical Technology and Precision Patient Care

    Following the signing of a Memorandum of Understanding (MOU) in 2024, Taiwan’s China Medical University Hospital (CMUH) and Malaysia’s Universiti Malaysia Sarawak (UNIMAS) have established a long-term collaborative partnership aimed at driving innovation in healthcare. On 12th July, in Kuching, Sarawak, the two institutions co-hosted their first major academic event – a joint symposium titled “Advances in Medical Technology and Patient Care Symposium.” This symposium spotlighted frontier advancements in medical technology and clinical care, including obesity management, cancer proton therapy, medical artificial intelligence, Parkinson’s disease interventions, and atrial fibrillation treatment. In his opening remarks, Dr. Chih-Kun Huang, Superintendent of International Center at CMUH, remarked, “This symposium not only showcases Taiwan’s achievements in precision medicine and innovation but also marks a new chapter of collaboration with Malaysia. We look forward to deepening our shared mission of improving health outcomes across borders.” China Medical University Hospital (CMUH) in Taiwan and Universiti Malaysia Sarawak (Unimas) co-hosted the '2025 Advances in Medical Technology and Patient Care Symposium' in Kuching on July 12, attracting over 200 participants and receiving an enthusiastic response. Multidisciplinary Strategies in Obesity Treatment: A New Era of Innovation Dr. Chih-Kun Huang, Superintendent of International Center, CMUH, shared insights in his keynote titled “The Trend and Future of Obesity Treatment.” He addressed the global obesity epidemic and the limitations of conventional methods such as lifestyle modification and pharmacotherapy. Dr. Huang highlighted the emergence of novel anti-obesity agents targeting appetite and energy regulation, along with hormonal modulation following bariatric surgery. He also emphasized the role of genetic and microbiome-based approaches in advancing personalized interventions, and the growing potential of endoscopic bariatric therapies as less invasive alternatives. Dr. Huang stressed that the future of obesity treatment lies in a multidisciplinary framework combining medical, behavioral, and technological strategies—especially relevant in countries like Malaysia where obesity prevalence is rising. Proton Therapy in Cancer Treatment: Precision with Fewer Side Effects Dr. Chun-Ru Chien, Director of Radiation Oncology Department at CMUH, delivered a presentation on “Proton Therapy in Cancer Treatment.” He compared conventional photon-based radiotherapy with proton therapy, an advanced modality offering superior dose conformity to tumors while sparing surrounding healthy tissue. Dr. Chien emphasized the clinical benefits for patients in both Taiwan and Malaysia and introduced CMUH’s new proton therapy center, established in 2024—Taiwan’s fifth and most advanced to date—signaling a commitment to global cancer care excellence. Medical AI: A Foundational Driver of Precision Medicine Dr. Wan-Yuo Guo, M.D., Ph.D., President of World Federation of Neuroradiological Societies (WFNRS), shared his expert perspective on “Medical AI as a Foundational Driver of Precision Medicine.” Dr. Guo illustrated how AI is revolutionizing healthcare by enabling integration and analysis of complex, multimodal datasets—such as imaging, genomics, pathology, and clinical records. He focused particularly on imaging AI’s ability to enhance diagnostic accuracy, detect disease earlier, and assist with personalized risk stratification. He also discussed the role of federated learning and AI-driven clinical decision support systems, highlighting AI’s transition from supportive technology to a central enabler of predictive, preventive, and participatory medicine. Dual-Target MRgFUS: A Breakthrough in Parkinson’s Disease Care Dr. Jui-Cheng Chen, Director of Neurology Department at CMUH, introduced a groundbreaking advancement in movement disorder treatment with his talk on “Revolutionizing Parkinson’s Care: Dual-Target MRgFUS for Comprehensive Symptom Relief.” He presented the world’s first dual-target MR-guided Focused Ultrasound (MRgFUS) procedure, which simultaneously ablates the ventral intermediate nucleus (VIM) and the pallidothalamic tract (PTT). This innovation offers comprehensive relief for Parkinson’s symptoms, addressing both tremor and rigidity in a non-invasive, incision-free manner. For patients ineligible for deep brain stimulation, this minimally invasive therapy with immediate results and high safety is redefining standard care in Parkinson’s management. Atrial Fibrillation: Concomitant Ablation and LAA Closure for Better Outcomes Dr. Yen-Nien Lin, MD, Director of Cardiac Arrhythmia Center, CMUH, presented on “Best Atrial Fibrillation Management: Concomitant Atrial Fibrillation Ablation and Left Atrial Appendage Closure—The CMUH Experience.” He outlined an integrated treatment approach for patients with symptomatic AF and elevated stroke risk, combining catheter ablation with left atrial appendage closure (LAAC) in a single procedure. This strategy addresses both arrhythmogenic foci and thromboembolic sources, reducing the need for lifelong anticoagulation. Drawing on findings from major clinical trials like aMAZE and AMULET IDE, Dr. Lin discussed procedural techniques, device deployment, and post-operative management—emphasizing the value of a tailored, multidisciplinary protocol to enhance long-term patient outcomes. From the UNIMAS side, Prof. Dr. Edmund Sim, from the Faculty of Resource Science and Technology, introduced CARISA (Cancer Risk Assessment Toolkit), a multilingual digital platform designed to empower Malaysians in early self-assessment of cancer risks. Early Cancer Detection through CARISA Toolkit Highlighting the burden of cancers such as breast, nasopharyngeal, cervical, lung, and colorectal in Malaysia, Prof. Edmund emphasized the critical need for culturally adapted, evidence-based tools that enable personalized, pre-symptomatic risk screening. CARISA, a subscription-based toolkit, integrates five disease-specific modules, i.e., BreCRA, NasoCRA, CerviCRA, LunCRA, and ColoCRA, each built on Malaysian national cancer registry data, systematic reviews, and clinical expert consensus. As noted by Prof Edmund, what makes CARISA unique is not just its scientific rigor, but its inclusivity within the Sarawakian context. The tool supports English, Malay, Mandarin, and Iban languages, mirroring the rich linguistic diversity of Malaysia, especially in Sarawak. Otology Implants: Transforming Hearing Care Meanwhile, Prof. Dr. Ing Ping Tang, a senior consultant in Otorhinolaryngology Head and Neck Surgery (ORL-HNS) from the Faculty of Medicine and Health Sciences, presented a review on new advances in otology implants that have expanded beyond traditional cochlear devices. His session provided a deep dive into various implantable technologies, including Bone Conduction Implant, Cochlear Implant, Middle Ear Implant, Passive Middle Ear Implant and also Auditory Brainstem Implants. Of particular interest were discussions around extended candidacy for patients with atypical anatomies or minimal benefit from conventional hearing aids. This symposium marks the first large-scale academic collaboration between CMUH and UNIMAS since the signing of their MOU, and sets a new benchmark for medical innovation, education, and cross-border collaboration. By facilitating knowledge exchange and showcasing precision medicine advancements, this event exemplifies a joint commitment to improving healthcare outcomes across Asia and beyond.

First page
1 2 3
Last Page
Is the information helpful to you? Yes No
Display the Menu
Close the Menu
Back Top